Capital Growth Management LP Pfizer Inc Transaction History

Capital Growth Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $2.79 Million - $3.31 Million	60,000 New	60,000 $3.15 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $1.51 Million - $1.83 Million	-50,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $1.35 Million - $1.93 Million	50,000 New	50,000 $1.63 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Capital Growth Management LP, based on Form 13F filings with the SEC.

Stay updated on Capital Growth Management LP with notifications on news.